Jalen Hurts’ Blood Clot: The NFL and Players Are Scrutinizing the Case Closely

The Jalen Hurts case is taking an official turn. The NFL and the Players Association (NFLPA) announced Sunday, in a joint statement, that they would jointly review how the Philadelphia Eagles quarterback's blood clot was handled.

The union had called for an investigation earlier in the week. The league ultimately agreed to cooperate.

Hurts' condition is serious. Placed on the injured reserve list, he is expected to miss the rest of the season. A blood clot that formed in his left calf traveled to his lungs. On Monday, the Eagles and his agent, Nicole Lynn, confirmed that he was suffering from deep vein thrombosis and bilateral pulmonary embolisms.

The player is now being treated with anticoagulants. As long as he is taking this medication, he will be prohibited from participating in any football-related activities.

A Timeline That Raises Questions

According to the Eagles, it all began on October 4 against the Los Angeles Rams, when Hurts was struck in the calf by a cleat. However, he did not report the injury to the medical staff until after practice on October 8.

The MVP of Super Bowl 59 returned to practice the very next day and then flew with the team to London to face the Jacksonville Jaguars. Once there, specialists initially diagnosed him with superficial vein thrombosis. Hurts therefore played in the October 11 game.

It is this sequence of events that is now raising questions.

Dr. Allen Sills, the NFL's chief medical officer, has nevertheless vigorously defended the work of the team's medical staff. On Wednesday, Commissioner Roger Goodell expressed similar confidence. According to him, the medical evaluation took place and protocols were strictly followed—a fact that the league's chief medical officer reportedly verified.

It remains to be seen whether the joint review will reach the same conclusion.

Created by humans, assisted by AI.